Will investments in biobanks, prospective cohorts, and markers of common patterns of variation benefit other populations for drug response and disease susceptibility gene discovery?

Pharmacogenomics Journal

Volumn 5, Issue 2, 2005, Pages 75-80

  Foster, Morris W ^a   Sharp, R R ^b  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CHINA; COHORT ANALYSIS; DISEASE PREDISPOSITION; DNA DETERMINATION; DRUG RESPONSE; ENVIRONMENTAL FACTOR; FINANCIAL MANAGEMENT; FOUNDER EFFECT; GENE FREQUENCY; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DRIFT; GENETIC LINKAGE; GENETIC RECOMBINATION; GENETIC SELECTION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HEALTH CARE FACILITY; HIGH THROUGHPUT SCREENING; HUMAN; INVESTMENT; JAPAN; MOLECULAR CLONING; PHARMACOGENETICS; POPULATION GENETICS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES; WESTERN EUROPE;

COHORT STUDIES; DATABASES, GENETIC; DRUG DESIGN; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PHENOTYPE; POPULATION; PROSPECTIVE STUDIES; VARIATION (GENETICS);

EID: 16344382361     PISSN: 1470269X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500295     Document Type: Article

References (34)

1. Carlson CS, Eberle MA, Kruglyak L, Nickerson DA. Mapping complex disease loci in whole-genome association studies. Nature 2004; 429: 446-452.
2. Goldstein DB, Ahmadi KR, Weale ME, Wood NW. Genome scans and candidate gene approaches in the study of common diseases and variable drug responses. Trends Genet 2003; 19: 615-622.
3. Wilson JF, Weale ME, Smith AC, Gratrix F, Fletcher B, Thomas MG et al. Population genetic structure of variable drug response. Nat Genet 2001; 29: 265-269.
4. International HapMap Consortium. The International HapMap Project. Nature 2003; 426: 789-796.
5. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-2229.
6. Johnson GCL, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001; 29: 233-237.
7. Deloukas P, Bentley D. The HapMap Project and its applications to genetic studies of drug response. Pharmacogenom J 2004; 4: 88-90.
8. Zhao HY, Pfeiffer R, Gail MH. Haplotype analysis in population genetics and association studies. Pharmacogenomics 2003; 4: 171-178.
9. Pritchard JK, Cox NJ. The allelic architecture of human disease genes: common disease - common variant ... or not? Hum Mol Genet 2002; 11: 2417-2423.
10. Chakravarti A. Population genetics - making sense out of sequence. Nat Genet 1999; 21: 56-60.
11. Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet 2001; 17: 502-510.
12. Weiss KM, Terwilliger JD. How many diseases does it take to map a gene with SNPs? Nat Genet 2000; 26: 151-157.
13. Clark AG. Finding genes underlying risk of complex disease by linkage disequilibrium mapping. Curr Opin Genet Dev 2003; 13: 296-302.
14. Smith DJ, Lusis AJ. The allelic structure of common disease. Hum Mol Genet 2002; 11: 2455-2461.
15. Zondervan KT, Cardon LR. The complex interplay among factors that influence allelic association. Nat Rev Genet 2004; 5: 89-100.
16. Weiss KM, Clark AG. Linkage disequilibrium and the mapping of complex human traits. Trends Genet 2002; 18: 19-24.
17. Van Den Oord EJCG, Neale BM. Will haplotype maps be useful for finding genes? Mol Psychiatry 2004; 9: 227-236.
18. Goldstein DB. Islands of linkage disequilibrium. Nat Genet 2001; 29: 109-111.
19. Tishkoff SA, Verrelli BC. Patterns of human genetic diversity: implications for human evolutionary history and disease. Ann Rev Genom Hum Genet 2003; 4: 293-340.
20. Pe'er I, Beckmann JS. On the applicability of a haplotype map to un-assayed populations. Hum Genet 2004; 114: 214-217.
21. Collins FS. The case for a US prospective cohort study of genes and environment. Nature 2004; 429: 475-477.
22. Gulcher J, Stefansson K. Population genomics: laying the groundwork for genetic disease modeling and targeting. Clin Chem Lab Med 1998; 36: 523-527.
23. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986; 232: 34-47.
24. Maron DJ, Fazio S, Linton MF. Current perspectives on statins. Circulation 2000; 101: 207-213.
25. Barbour V. UK Biobank: a project in search of a protocol? Lancet 2003; 361: 1734-1738.
26. Wong MY, Day NE, Luan JA, Chan KP, Wareham NJ. The detection of gene-environment interaction for continuous traits: should we deal with measurement error by bigger studies or better measurement? Int J Epidemiol 2003; 32: 51-57.
27. Weisgraber KH, Mahley RW. Human apolipoprotein E: the Alzheimer's disease connection. FASEB J 11996; 10: 1485-1494.
28. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High-risk of thrombosis in patients homozygous for factor-V Leiden (activated protein-c resistance). Blood 1995; 85: 1504-1508.
29. Martinson JJ, Chapman NH, Rees DC, Liu YT, Clegg JB. Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet 1997; 16: 100-103.
30. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002; 4: 45-61.
31. McCarthy MI. Progress in defining the molecular basis of type 2 diabetes mellitus through susceptibility-gene identification. Hum Mol Genet 2004; 13: R33-R41, (Sp. Iss. 1).
32. Thompson JF, Lloyd DB, Lira ME, Milos PM. Cholesteryl ester transfer protein promoter single-nucleotide polymorphisms in Sp1-binding sites affect transcription and are associated with high-density lipoprotein cholesterol. Clin Genet 2004; 66: 223-228.
33. Newman DL, Hoffjan S, Bourgain C, Abney M, Nicolae RI, Profits ET et al. Are common disease susceptibility alleles the same in outbred and founder populations? Eur J Hum Genet 2004; 12: 584-590.
34. Morabia A, Cayanis E, Costanza MC, Ross BM, Bernstein MS, Flaherty MS et al. Association between lipoprotein lipase (LPL) gene and blood lipids: a common variant for a common trait? Genet Epidemiol 2003; 24: 309-321.